Beyond the hype: Balancing speed, security and value
Globally, the life sciences sector is working on improving operations and creating new value by transforming digitally. In a highly regulated sector where companies are often fragmented and siloed, transforming at scale can be difficult. For these reasons, it can be helpful for tech function leaders to compare their decision making against their peers in the sector and other industries.
The KPMG global tech report: Life sciences insights examines the views of 123 senior-level life sciences technology function leaders from around the world that include chief digital officers, CIOs, CTOs, CISOs, chief AI officers and others.
This report contains valuable insights into how life sciences organizations are navigating the complexities of digital transformation and covers topics that include technology investment decision making, data, AI and cyber security.
Only 59 percent of life sciences respondents say their tech investment decision-making processes usually result in sound decisions that lead to valuable outcomes.
Life sciences leads all of the eight industries surveyed in prioritizing and investing in edge and quantum computing, VR/AR/XR, spatial computing, XaaS technology and modern delivery.
More than one-third of life sciences respondents say their organizations are using AI at scale and are achieving returns on investment.
61 percent of life sciences respondents worry that cyber security is frequently treated as a box-ticking exercise in staff training and isn’t embedded as extensively as it could be.
Read the full report to explore more insights and KPMG life sciences technology specialist perspectives on the findings, and to obtain actionable recommendations for addressing life sciences organization technology challenges.
The insights in this report were derived from the KPMG global tech report 2024, a survey of 2,450 technology leaders from 26 countries across 8 industries: financial services, technology, retail and consumer packaged goods, industrial manufacturing, life sciences, healthcare, government and public sector, and energy. Survey respondents represented organizations with annual operating budgets or revenues above US$100M-plus.
Life sciences respondent demographics: 123 life sciences technology function leaders were surveyed of which a significant portion (85 percent) held C-suite or department head, EVP, SVP or VP level positions. A strong majority (86 percent) of these respondents represented life sciences organizations with revenues of US$10B to US$50B-plus.
Our thinking: A new era of precision medicine
A new era of precision medicine: The unprecedented impact of generative AI across the precision medicine landscape